SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | n/a |
Enterprise Value ($M) | n/a |
Book Value ($M) | 14.89 |
Book Value / Share | 0.28 |
Price / Book | n/a |
NCAV ($M) | 12.10 |
NCAV / Share | 0.23 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.30 |
Return on Assets (ROA) | -0.60 |
Return on Equity (ROE) | -0.91 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.97 |
Current Ratio | 1.97 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 25.02 |
Assets | 27.81 |
Liabilities | 12.92 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Sofinnova Venture Partners VIII, L.P. | 11.90 | -22.25 | |
13G/A | Griffith Hugh | 11.00 | 20.97 | |
13G/A | Baillie Gifford & Co | 6.98 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
188,193 | 1,033,059 | 18.22 | |
33,066 | 127,028 | 26.03 | |
111,481 | 457,965 | 24.34 | |
106,546 | 332,381 | 32.06 | |
(click for more detail) |
Similar Companies | |
---|---|
AADI – Aadi Bioscience, Inc. | ABEO – Abeona Therapeutics Inc. |
ABIO – ARCA biopharma, Inc. | ABVC – ABVC BioPharma, Inc. |
ACB – Aurora Cannabis Inc. |
Financial data and stock pages provided by
Fintel.io